XML 74 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segments
 12 Months Ended
Dec. 31, 2013
Segment Reporting [Abstract]  
Business Segments
Business Segments.
 
The Company has four reportable segments: Apex, Oxford, Life Sciences, and Physician.

The Apex segment provides mission-critical IT operations professionals for contract, contract-to-hire and permanent placement positions to Fortune 1000 and mid-market clients across the United States, and offers consulting services for other select project-based needs. Apex provides staffing and services support for companies from all major industries, including financial services, business services, consumer and industrials, technology, healthcare, government services, and communications.

The Oxford segment provides high-end contract and direct placement services of information technology and engineering professionals with expertise in specialized information technology; software and hardware engineering; and mechanical, electrical, validation and telecommunications engineering fields.

The Life Sciences segment provides contract, contract-to-permanent and direct placement services of laboratory and scientific professionals to the biotechnology, pharmaceutical, food and beverage, medical device, personal care, chemical and environmental industries. These contract staffing specialties include chemists, clinical research associates, clinical lab assistants, engineers, biologists, biochemists, microbiologists, molecular biologists, food scientists, regulatory affairs specialists, lab assistants and other skilled scientific professionals.

The Physician segment provides contract and direct placement physicians to healthcare organizations. The Physician segment works with nearly all medical specialties, placing locum tenens physicians in hospitals, community-based practices, and federal, state and local facilities.

During 2013, the Company sold its Nurse Travel line of business and most of the Allied Healthcare line of business. See Note 4 Discontinued Operations for further information. As a result of these sales, the Healthcare segment no longer exists and Health Information Management ("HIM"), formerly included in the Healthcare Segment, is included in the Oxford Segment and unallocated corporate expenses are separately disclosed in order to align with the revised internal reporting package reviewed by the Chief Operating Decision Maker. All prior periods have been restated to conform to this presentation.
   
The Company’s management evaluates the performance of each segment primarily based on revenues, gross profit and operating income. The information in the following table is derived directly from the segments’ internal financial reporting used for corporate management purposes.

The following table represents revenues, gross profit, operating income, amortization and total assets by reportable segment (in thousands):

 
Year ended December 31, 2013
 
Apex
 
Oxford
 
Life Sciences
 
Physician
 
Corporate
 
Total
Revenues
$
942,463

 
$
412,189

 
$
171,518

 
$
105,827

 
$
—

 
$
1,631,997

Gross Profit
258,150

 
143,334

 
56,308

 
30,614

 
—

 
488,406

Operating income
76,971

 
58,990

 
28,354

 
8,852

 
(49,199
)
 
123,968

Amortization
19,524

 
965

 
429

 
742

 
91

 
21,751

Total assets (1)
656,733

 
365,118

 
128,824

 
110,519

 
—

 
1,261,194


 
Year ended December 31, 2012
 
Apex
 
Oxford
 
Life Sciences
 
Physician
 
Corporate
 
Total
Revenues
$
508,743

 
$
363,765

 
$
162,799

 
$
102,679

 
$
—

 
$
1,137,986

Gross Profit
140,669

 
127,895

 
55,874

 
31,455

 
—

 
355,893

Operating income
36,416

 
56,289

 
25,632

 
9,998

 
(47,154
)
 
81,181

Amortization
15,665

 
437

 
807

 
817

 
290

 
18,016

Total assets (1)
642,594

 
235,099

 
150,696

(2) 
86,074

 
—

 
1,114,463

 
Year ended December 31, 2011
 
Apex

 
Oxford

 
Life Sciences

 
Physician

 
Corporate
 
Total
Revenues
$
—

 
$
279,643

 
$
155,324

 
$
80,617

 
$
—

 
$
515,584

Gross Profit
—

 
99,187

 
52,643

 
25,858

 
—

 
177,688

Operating income
—

 
37,676

 
24,883

 
6,699

 
(30,625
)
 
38,633

Amortization
—

 
821

 
901

 
415

 
209

 
2,346

Total assets (1)
—

 
221,690

 
119,563

(2) 
86,014

 
—

 
427,267

______
 
 
 
 
 
 
 
 
 
 
 
(1) As of end of the year.
(2) Life Sciences total assets as of December 31, 2012 and 2011 include assets related to the Healthcare segment, which were sold and included in discontinued operations in 2013. Historically, the Company has not reported Life Science and Healthcare segments' total assets separately as the operations were largely centralized.
 
  
The Company operates internationally, with operations in the United States, Europe, Canada, China, Australia, and New Zealand. The following table represents revenues by geographic location (in thousands):
 
 
Year Ended December 31,
 
 
2013
 
2012
 
2011
Revenues:
 
 
 
 
 
 
Domestic
 
$
1,552,322

 
$
1,060,217

 
$
447,453

Foreign
 
79,675

 
77,769

 
68,131

 
 
$
1,631,997

 
$
1,137,986

 
$
515,584


 
The following table represents long-lived assets by geographic location (in thousands):
 
 
December 31,
 
 
2013
 
2012
 
2011
Long-lived Assets:
 
 
 
 
 
 
Domestic
 
$
45,061

 
$
40,062

 
$
19,078

Foreign
 
2,856

 
2,006

 
1,033

 
 
$
47,917

 
$
42,068

 
$
20,111